Single nucleotide polymorphisms in microRNAs action as biomarkers for breast cancer

MicroRNAs (miRNAs) have been recently described as small noncoding RNAs that are involved in numerous crucial physiological processes, such as cell cycles, differentiation, development, and metabolism. Thus, dysregulation of these molecules could lead to several severe disorders, including breast cancer (BC). Ongoing investigations in malignant growth diagnostics have distinguished miRNAs as promising disease biomarkers. As with any other mRNAs, single nucleotide polymorphisms (SNPs) in DNA sequence encoding for miRNA (miR-SNPs) indeed lead to potential changes in the function of miRNA. In this study, miR-SNPs located in different miRNA sequence regions, which have been associated with BC in different ways, and the potential mechanisms of how these miR-SNPs develop the risk of the disease were discussed.

___

  • Alshatwi AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030049
  • Auyeung VC, 2013, CELL, V152, P844, DOI 10.1016/j.cell.2013.01.031
  • Aviv A, 2017, TRENDS CANCER, V3, P253, DOI 10.1016/j.trecan.2017.02.005
  • Bansal C, 2014, ECANCERMEDICALSCIENC, V8, DOI 10.3332/ecancer.2014.473
  • Bensen JT, 2018, BREAST CANCER RES, V20, DOI 10.1186/s13058-018-0964-4
  • Cammaerts S, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00186
  • Catalanotto C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101712
  • Chacon-Cortes D, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0248-0
  • Chacon-Cortes D, 2015, TUMOR BIOL, V36, P5369, DOI 10.1007/s13277-015-3200-1
  • Chen JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086319
  • Chen KX, 2008, CARCINOGENESIS, V29, P1306, DOI 10.1093/carcin/bgn116
  • Chen QH, 2014, TUMOR BIOL, V35, P529, DOI 10.1007/s13277-013-1074-7
  • Cheng Q, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3168
  • Cho WCS, 2011, RNA BIOL, V8, P125, DOI 10.4161/rna.8.1.14259
  • Dai ZJ, 2015, CURR PHARM DESIGN, V21, P1455, DOI 10.2174/1381612821666141208143533
  • Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010
  • Duan XR, 2020, SCI TOTAL ENVIRON, V703, DOI 10.1016/j.scitotenv.2019.135600
  • Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887
  • Feng XL, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20190741
  • Fu A, 2014, EPIGENETICS-US, V9, P730, DOI 10.4161/epi.27996
  • Gao JS, 2010, NUCLEIC ACIDS RES, V38, P2775, DOI 10.1093/nar/gkp1242
  • Gu S, 2012, CELL, V151, P900, DOI 10.1016/j.cell.2012.09.042
  • Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043
  • Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504
  • Hashemi M., 2016, Experimental Oncology, V38, P57
  • Hoffman AE, 2009, CANCER RES, V69, P5970, DOI 10.1158/0008-5472.CAN-09-0236
  • Hu WQ, 2012, CELL RES, V22, P1322, DOI 10.1038/cr.2012.80
  • Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837
  • Huang AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035252
  • Iwakawa HO, 2015, TRENDS CELL BIOL, V25, P651, DOI 10.1016/j.tcb.2015.07.011
  • Jiao LH, 2014, AM J TRANSL RES, V6, P869
  • Kazemi Arezu, 2020, Microrna, V9, P133, DOI 10.2174/2211536608666190926155149
  • Kim VN, 2004, TRENDS CELL BIOL, V14, P156, DOI 10.1016/j.tcb.2004.02.006
  • Kontorovich T, 2010, INT J CANCER, V127, P589, DOI 10.1002/ijc.25065
  • Lehmann TP, 2013, ONCOL LETT, V5, P569, DOI 10.3892/ol.2012.1040
  • Lerner M, 2011, CELL CYCLE, V10, P2172, DOI 10.4161/cc.10.13.16248
  • Li JT, 2015, ONCOTARGET, V6, P30818, DOI 10.18632/oncotarget.5067
  • Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074504
  • Lian H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031615
  • Lin J, 2011, CARCINOGENESIS, V32, P1641, DOI 10.1093/carcin/bgr199
  • Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174
  • McNally EJ, 2019, J CLIN INVEST, V129, P3474, DOI 10.1172/JCI120851
  • Mir R, 2018, Asian Pac J Cancer Prev, V19, P2581
  • Morales S, 2018, GENES-BASEL, V9, DOI 10.3390/genes9090427
  • Morales S, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0415-0
  • Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541
  • O'Brien J, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00402
  • Qiu LX, 2011, CYTOKINE, V56, P589, DOI 10.1016/j.cyto.2011.08.019
  • Ryan BM, 2017, ADV CANCER RES, V135, P151, DOI 10.1016/bs.acr.2017.06.004
  • Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867
  • Said BI, 2015, CANCER GENET-NY, V208, P47, DOI 10.1016/j.cancergen.2014.12.003
  • Schulman BRM, 2005, DEV DYNAM, V234, P1046, DOI 10.1002/dvdy.20599
  • Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200
  • Shastry BS, 2009, METHODS MOL BIOL, V578, P3, DOI 10.1007/978-1-60327-411-1_1
  • Shen J, 2008, CARCINOGENESIS, V29, P1963, DOI 10.1093/carcin/bgn172
  • Smith RA, 2012, CANCER GENOM PROTEOM, V9, P115
  • Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064
  • Starega-Roslan J, 2011, NUCLEIC ACIDS RES, V39, P257, DOI 10.1093/nar/gkq727
  • Stoicea N, 2016, FRONT GENET, V7, DOI [10.3339/fgene.2016.00011, 10.3389/fgene.2016.00011]
  • Sun GH, 2009, RNA, V15, P1640, DOI 10.1261/rna.1560209
  • Sung H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-195
  • Tian Y, 2014, MOL CELL, V53, P606, DOI 10.1016/j.molcel.2014.01.003
  • Minh TTH, 2018, INT J HUM GENET, V18, P238, DOI 10.31901/24566330.2018/18.3.658
  • Tsutsumi A, 2011, NAT STRUCT MOL BIOL, V18, P1153, DOI 10.1038/nsmb.2125
  • Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013
  • Wang L, 2014, CELL PHYSIOL BIOCHEM, V34, P413, DOI 10.1159/000363010
  • Wang R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046173
  • Wazir U, 2019, CANCER GENOM PROTEOM, V16, P121, DOI 10.21873/cgp.20117
  • WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4
  • Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005
  • Xiao JN, 2011, EMBO J, V30, P524, DOI 10.1038/emboj.2010.347
  • Xiong XX, 2013, MOL CELLS, V36, P518, DOI 10.1007/s10059-013-0171-1
  • Yamagata K, 2014, MOL CELL, V54, P536, DOI 10.1016/j.molcel.2014.04.018
  • Yan WJ, 2017, ONCOTARGET, V8, P114344, DOI 10.18632/oncotarget.22547
  • Yan X, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-220
  • Yang RX, 2010, BREAST CANCER RES TR, V121, P693, DOI 10.1007/s10549-009-0633-5
  • Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803
  • Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079
  • Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491
  • Zeng Y, 2005, J BIOL CHEM, V280, P27595, DOI 10.1074/jbc.M504714200
  • Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017
  • Zhang H, 2017, ONCOTARGET, V8, P46969, DOI 10.18632/oncotarget.16443
  • Zhang H, 2017, ONCOTARGET, V8, P393, DOI 10.18632/oncotarget.13426
  • Zhang N, 2013, GENE, V529, P125, DOI 10.1016/j.gene.2013.07.041
  • Zhao HH, 2015, TUMOR BIOL, V36, P4763, DOI 10.1007/s13277-015-3126-7
  • Zheng H, 2011, INT J ONCOL, V38, P1153, DOI 10.3892/ijo.2011.940
  • Zhou CH, 2014, BIOPHYS J, V106, P1792, DOI 10.1016/j.bpj.2014.02.032
Turkish Journal of Biology-Cover
  • ISSN: 1300-0152
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK